Herbal medicinal product: Verbasci flos, Verbascum thapsus L.; V. densiflorum Bertol. (V. thapsiforme Schrad); V. phlomoides L., C: ongoing call for scientific data

Herbal medicinal product: Verbasci flos, Verbascum thapsus L.; V. densiflorum Bertol. (V. thapsiforme Schrad); V. phlomoides L., C: ongoing call for scientific data

Opinion/decision on a Paediatric investigation plan (PIP): Qdenga, Dengue tetravalent vaccine (live, attenuated), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number:

Opinion/decision on a Paediatric investigation plan (PIP): Qdenga, Dengue tetravalent vaccine (live, attenuated), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0003/2024

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, Upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0010/2024

Opinion/decision on a Paediatric investigation plan (PIP): Rinvoq, Upadacitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immune system disorders, PIP number: P/0010/2024

European Shortages Monitoring (ESMP) - Question and answer clinic for marketing authorisation holders on shortage reporting via ESMP, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2025, 10:00 (CET) to 25 Februa

European Shortages Monitoring (ESMP) - Question and answer clinic for marketing authorisation holders on shortage reporting via ESMP, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 February 2025, 10:00 (CET) to 25 February 2025, 11:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness